Cantor Fitzgerald downgraded Replimune (REPL) to Neutral from Overweight.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REPL:
- Replimune downgraded to Neutral at Piper Sandler after second CRL
- Replimune downgraded to Neutral from Overweight at Piper Sandler
- Replimune CRL positive for Iovance in near-term, says Chardan
- Iovance could advance 5%-15% on Replimune rejection, says Jefferies
- Replimune issued Complete Response Letter for RP1 for advanced melanoma